Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

被引:28
|
作者
Wingate, Jonathan T. [1 ]
Brandenberger, Jared [2 ]
Weiss, Andrew [3 ]
Scovel, Lauren G. [2 ]
Kuhr, Christian S. [2 ]
机构
[1] Madigan Army Med Ctr, Dept Urol, Tacoma, WA 98431 USA
[2] Virginia Mason Med Ctr, Dept Urol & Renal Transplantat, Seattle, WA 98101 USA
[3] Virginia Mason Med Ctr, Dept Nephrol & Renal Transplantat, Seattle, WA 98101 USA
关键词
bacteriuria; BK nephropathy; BK viremia; ureteral stent; URINARY-TRACT-INFECTION; SINGLE-CENTER EXPERIENCE; UROLOGICAL COMPLICATIONS; RENAL-TRANSPLANTATION; NEPHROPATHY; IMPACT; RECIPIENTS; VIRUS;
D O I
10.1111/tid.12644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesUreteral stents are used in kidney transplantation (KTX) to decrease post-operative complications, but they are associated with BK polyomavirus viremia (BKV). Our primary outcome was to determine the association between ureteral stent duration and BKV. Secondary outcome measures were the association between bacteriuria and stent duration or use of ureteral stent strings. MethodsBetween January 2010 and January 2015, 403 patients underwent KTX at the Virginia Mason Medical Center and met inclusion criteria. Stent duration was classified as short (<3weeks) or long (>3weeks). Multivariate logistic regression models were created to assess for factors associated with BKV. The covariates in the BKV model were chosen a priori based on stent duration and risk factors previously described in the literature. ResultsUreteral stents were placed in 304 (75.4%) transplants. Stent strings were left attached in 166 (54.6%) patients. On multivariate analyses, long stent duration was significantly associated with increased risk of BKV compared with no stent (odds ratio [OR] 1.92, P=.044, 95% confidence interval [CI] 1.04-3.74). Short stent duration was not associated with BKV. Sixty-two (15.4%) patients had bacteriuria. Bacteriuria was associated with female gender (OR 2.77, P<.001, 95% CI 1.58-4.95), and there was a dose-dependent effect with stent duration compared with no stentshort duration (OR 2.46, P=.049, 95% CI 1.05-6.49) and long duration (OR 3.58, P=.004, 95% CI 1.58-9.25). Stent strings were not associated with either complication. ConclusionsThe association between ureteral stents and BKV may be dose dependent.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Polyomavirus BK Viremia in Kidney Transplant Recipients After Desensitization With IVIG and Rituximab
    Barbosa, Debora
    Kahwaji, Joseph
    Puliyanda, Dechu
    Mirocha, James
    Reinsmoen, Nancy
    Lai, Chih-Hung
    Villicana, Rafael
    Peng, Alice
    Jordan, Stanley C.
    Vo, Ashley
    Toyoda, Mieko
    TRANSPLANTATION, 2014, 97 (07) : 755 - 761
  • [22] Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review
    Demey, Baptiste
    Tinez, Claire
    Francois, Catherine
    Helle, Francois
    Choukroun, Gabriel
    Duverlie, Gilles
    Castelain, Sandrine
    Brochot, Etienne
    JOURNAL OF CLINICAL VIROLOGY, 2018, 109 : 6 - 12
  • [23] Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation
    Krejci, Karel
    Tichy, Tomas
    Bednarikova, Jana
    Bartkova, Margita
    Zamboch, Kamil
    Orsag, Jiri
    Zadrazil, Josef
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3871 - 3879
  • [24] BK Viremia After Kidney Transplantation: Efficacy of Stepwise Treatments
    Cho, A.
    Woo, H.
    Jo, E.
    Ko, M.
    Han, A.
    Min, S.
    Ha, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S792 - S793
  • [25] REPLICATION OF HUMAN POLYOMAVIRUS BK BEFORE AND AFTER KIDNEY TRANSPLANTATION
    Barile, Mario
    Pietropaolo, Valeria
    Tinti, Francesca
    Umbro, Ilaria
    Fioriti, Daniela
    Guidi, Silvia
    Mischitelli, Monica
    Limonta, Alessandro
    Ferretti, Giancarlo
    Poli, Luca
    Chiarini, Fernanda
    Taliani, Gloria
    Berloco, Pasquale B.
    Mitterhofer, Anna Paola
    TRANSPLANT INTERNATIONAL, 2009, 22 : 358 - 358
  • [26] Antiviral treatment of BK virus viremia after kidney transplantation
    Santeusanio, Andrew D.
    Lukens, Benjamin E.
    Eun, Judy
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (24) : 2037 - 2045
  • [27] Epidemiology and Dynamics of BK Polyomavirus Replication after Kidney Transplantation
    Brochot, Etienne
    Demey, Baptiste
    Aubry, Aurelien
    Descamps, Veronique
    Morel, Virginie
    Presne, Claire
    Brazier, Francois
    Helle, Francois
    PATHOGENS, 2024, 13 (04):
  • [28] Polyomavirus BK-specific immunity after kidney transplantation
    Comoli, P
    Azzi, A
    Maccario, R
    Basso, S
    Botti, G
    Basile, G
    Fontana, L
    Labirio, M
    Cometa, A
    Poli, F
    Perfumo, F
    Locatelli, F
    Ginevri, F
    TRANSPLANTATION, 2004, 78 (08) : 1229 - 1232
  • [29] Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation
    van Rijn, Aline L.
    Wunderink, Herman F.
    de Brouwer, Caroline S.
    van der Meijden, Els
    Rotmans, Joris I.
    Feltkamp, Mariet C. W.
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (06) : 1142 - 1147
  • [30] Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation
    Wunderink, H. F.
    van der Meijden, E.
    van der Blij-de Brouwer, C. S.
    Mallat, M. J. K.
    Haasnoot, G. W.
    van Zwet, E. W.
    Claas, E. C. J.
    de Fijter, J. W.
    Kroes, A. C. M.
    Arnold, F.
    Touze, A.
    Claas, F. H. J.
    Rotmans, J. I.
    Feltkamp, M. C. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 161 - 172